Summit Therapeutics Inc. Number Of Instruments Other Equity Instruments Granted
Summit Therapeutics Inc. (SMMT) reported Number Of Instruments Other Equity Instruments Granted of 0 shares for the 9-month period ending 2019-10-31, per its 6-K filed 2019-12-17.
Discontinued › Notes › Shares
ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted · last filed 2019-12-17
- Summit Therapeutics Inc. number of instruments other equity instruments granted for the quarter ending 2019-10-31 was 0.00 shares.
- Summit Therapeutics Inc. number of instruments other equity instruments granted for the quarter ending 2019-07-31 was 0.00 shares.
- Summit Therapeutics Inc. number of instruments other equity instruments granted for the quarter ending 2019-04-30 was 0.00 shares, a 100.00% decline year-over-year.
- Summit Therapeutics Inc. number of instruments other equity instruments granted for the quarter ending 2019-01-31 was 692.31K shares.
| Period end | Number Of Instruments Other Equity Instruments Granted 3 month | Number Of Instruments Other Equity Instruments Granted 6 month | Number Of Instruments Other Equity Instruments Granted 9 month | Number Of Instruments Other Equity Instruments Granted 12 month |
|---|---|---|---|---|
| 2019-10-31 | 0.00 shares derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | 0.00 shares derived: sum of 2 quarters · filed 2019-12-17 | 0.00 shares 6-K · filed 2019-12-17 | 692.31K shares derived: sum of 4 quarters · filed 2019-12-17 |
| 2019-07-31 | 0.00 shares derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | 0.00 shares 6-K · filed 2019-10-11 | 692.31K shares derived: sum of 3 quarters · filed 2019-10-11 | 692.31K shares derived: sum of 4 quarters · filed 2019-12-17 |
| 2019-04-30 | 0.00 shares 6-K · filed 2019-06-12 | 692.31K shares derived: sum of 2 quarters · filed 2019-06-12 | 692.31K shares derived: sum of 3 quarters · filed 2019-12-17 | 692.31K shares derived: sum of 4 quarters · filed 2019-12-17 |
| 2019-01-31 | 692.31K shares derived: 20-F 12 month − 6-K 9 month · filed 2019-03-29 | 692.31K shares derived: sum of 2 quarters · filed 2019-12-17 | 692.31K shares derived: sum of 3 quarters · filed 2019-12-17 | 814.26K shares 20-F · filed 2019-03-29 |
| 2018-10-31 | 0.00 shares derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | 0.00 shares derived: sum of 2 quarters · filed 2019-12-17 | 121.95K shares 6-K · filed 2019-12-17 | 121.95K shares derived: sum of 4 quarters · filed 2019-12-17 |
| 2018-07-31 | 0.00 shares derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | 121.95K shares 6-K · filed 2019-10-11 | 121.95K shares derived: sum of 3 quarters · filed 2019-10-11 | 260.84K shares derived: sum of 4 quarters · filed 2019-10-11 |
| 2018-04-30 | 121.95K shares 6-K · filed 2019-06-12 | 121.95K shares derived: sum of 2 quarters · filed 2019-06-12 | 260.84K shares derived: sum of 3 quarters · filed 2019-06-12 | 397.83K shares derived: sum of 4 quarters · filed 2019-06-12 |
| 2018-01-31 | 0.00 shares derived: 20-F 12 month − 6-K 9 month · filed 2019-03-29 | 138.89K shares derived: sum of 2 quarters · filed 2019-03-29 | 275.88K shares derived: sum of 3 quarters · filed 2019-03-29 | 275.88K shares 20-F · filed 2019-03-29 |
| 2017-10-31 | 138.89K shares derived: 6-K 9 month − 6-K 6 month · filed 2018-12-11 | 275.88K shares derived: sum of 2 quarters · filed 2018-12-11 | 275.88K shares 6-K · filed 2018-12-11 | |
| 2017-07-31 | 136.99K shares derived: 6-K 6 month − 6-K 3 month · filed 2018-09-20 | 136.99K shares 6-K · filed 2018-09-20 | ||
| 2017-04-30 | 0.00 shares 6-K · filed 2018-06-05 | |||
| 2017-01-31 | 0.00 shares 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |